Effect of endothelin(A)-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm

F. Cosentino, E. G. McMahon, J. S. Carter, Z. S. Katusic

Research output: Contribution to journalArticlepeer-review

51 Scopus citations


The present study was designed to determine whether an endothelin(A) (ET(A))-receptor antagonist BQ-123 (cyclo[Dtrp, Dasp, pro-D-Val-Leu]) or an ET-converting enzyme inhibitor phosphoramidon may prevent development of cerebral vasospasm after subarachnoid hemorrhage (SAH). A 'double hemorrhage' canine model of the disease was used (n = 17 dogs), and the degree of vasospasm of the basilar artery was assessed by angiography. Mongrel dogs of either sex were divided into three experimental groups: animals treated with daily intracisternal injections of BQ-123 (10-4 M; n = 6) or phosphoramidon (2 x 10-4 M; n = 6) and control animals treated with saline solution (n = 5). Diameter of basilar arteries in animals treated with saline solution was reduced by SAH to 56 ± 7% of control diameter. BQ-123 and phosphoramidon did not significantly affect SAH-induced vasospasm (diameters were 62 ± 0% and 56 ± 10% of control diameters for BQ-123 and phosphoramidon, respectively). In contrast, in isolated canine basilar arteries BQ-123 (10-5 M) selectively inhibited concentration-dependent contractions to ET-1 (10- 11-3 x 108 M; n = 5). Levels of immunoreactive ET in plasma and cerebrospinal fluid were not affected by development of vasospasm. These results suggest that intracisternal injections of ET(A)-receptor antagonist or phosphoramidon cannot prevent SAH-induced cerebral vasospasm and that ET- 1 may not be the major mediator responsible for the decrease in cerebral arterial diameter associated with SAH.

Original languageEnglish (US)
Pages (from-to)S332-S335
JournalJournal of Cardiovascular Pharmacology
Issue numberSUPPL. 8
StatePublished - 1993


  • BQ- 123
  • Cerebral vasospasm
  • Endothelin(A) receptor
  • Phosphoramidon
  • Subarachnoid hemorrhage

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Effect of endothelin(A)-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm'. Together they form a unique fingerprint.

Cite this